Aztreonam and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Aztreonam (aztreonam), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Neupogen, and have Pain.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Aztreonam. It is created by eHealthMe based on reports of 3,048 people who have side effects when taking Aztreonam from the FDA, and is updated regularly.

What is Aztreonam?

Aztreonam has active ingredients of aztreonam. eHealthMe is studying from 3,054 Aztreonam users. Check the latest studies of Aztreonam.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,956 drugs and 2,937 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 10, 2026

3,048 people reported to have side effects when taking Aztreonam.
Among them, 35 people (1.15%) have Hyperkalemia.

Among these 35 people:

How long have people been on Aztreonam when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Aztreonam? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Hyperkalemia when taking Aztreonam? *

What are other drugs people take besides Aztreonam? *

What are other side effects people have besides Hyperkalemia? *

Stress And Anxiety: 16 people, 45.71%
Anaemia (lack of blood): 15 people, 42.86%
Influenza Like Illness: 15 people, 42.86%
Infection: 15 people, 42.86%
Hypernatraemia (an abnormally high plasma concentration of sodium ions): 15 people, 42.86%
Wound Secretion: 14 people, 40.00%
Wound Complication: 14 people, 40.00%
Oral Discomfort (pain or irritation in mouth): 14 people, 40.00%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 14 people, 40.00%
Muscle Aches (muscle pain): 14 people, 40.00%

What are the existing conditions these people have? *

Pain: 16 people, 45.71%
Depression: 15 people, 42.86%
Anaemia (lack of blood): 15 people, 42.86%
Nausea (feeling of having an urge to vomit): 15 people, 42.86%
Multiple Myeloma (cancer of the plasma cells): 14 people, 40.00%
Nausea And Vomiting: 13 people, 37.14%
Insomnia (sleeplessness): 13 people, 37.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.57%
Constipation: 3 people, 8.57%
Burkholderia Cepacia Complex Infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Aztreonam and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aztreonam:

Aztreonam (3,054 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Aztreonam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,956 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,937 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam (the active ingredients of Aztreonam) and Aztreonam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.